IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, supplying promising breakthroughs across various clinical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, far more reputable substitute for therapeutic use, s